Where the World’s Best Science
Becomes Medicine

A scalable hub-and-spoke engine for global drug development

Our Approach

K2 Therapeutics is a biotech company built for global impact, with search and development capabilities unconstrained by modality or geography. We identify the world’s most innovative assets and translate them into great medicines through a disciplined development approach and lead by experienced drug developers. Our focus is on high-potential first- and best-in-class assets with meaningful potential for patient impact worldwide.
About us

Our Advantages

Development speed
with rigor

Advance programs through clinical proof of concept with disciplined execution and early attention to manufacturing, translational science, and commercial potential.

Hub-and-spoke
efficiency at scale

Centralized strategy and leadership combined with parallel, distributed development across multiple assets to drive efficiency, focus, and portfolio diversification.

Cross-regional collaboration for global-ready evidence

Cross-regional clinical execution across major geographical markets delivers globally relevant evidence, early derisking, and accelerates regulatory outcomes.

Our team

View More
Leadership
Team

Ansbert Gadicke, M.D.

EXECUTIVE CHAIRMAN

Team

Frank Neumann, M.D., Ph.D.

CHIEF MEDICAL OFFICER

Wujie

Wu Jie, M.S.

CHIEF BUSINESS OFFICER

05Jin Wang, M.D., Ph.D.

Jin Wang, M.D., Ph.D.

VP OF CLINICAL DEVELOPMENT

Team

David Kolesky, Ph.D.

HEAD OF CORPORATE DEVELOPMENT

Team

Grey Sieczkiewicz, J.D., Ph.D.

IP COUNSEL

07Binsen Li, Ph.D.

Binsen Li, Ph.D.

HEAD OF INVESTMENT & BUSINESS DEVELOPMENT

08Hao Xing, Ph.D.

Hao Xing, Ph.D.

DIRECTOR OF BUSINESS DEVELOPMENT

Contact us

Have questions about us or want to learn more?